持田製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2023/11/21 | 3,195 | 3,240 | 3,195 | 3,235 | +40 | +1.3% | 25,800 |
| 2023/11/20 | 3,235 | 3,245 | 3,180 | 3,195 | -40 | -1.2% | 30,100 |
| 2023/11/17 | 3,200 | 3,240 | 3,200 | 3,235 | +45 | +1.4% | 28,400 |
| 2023/11/16 | 3,225 | 3,260 | 3,180 | 3,190 | -75 | -2.3% | 43,200 |
| 2023/11/15 | 3,295 | 3,300 | 3,230 | 3,265 | -20 | -0.6% | 54,600 |
| 2023/11/14 | 3,310 | 3,310 | 3,285 | 3,285 | ±0 | ±0% | 23,200 |
| 2023/11/13 | 3,310 | 3,315 | 3,285 | 3,285 | -25 | -0.8% | 15,800 |
| 2023/11/10 | 3,270 | 3,315 | 3,265 | 3,310 | +5 | +0.2% | 21,200 |
| 2023/11/09 | 3,370 | 3,370 | 3,270 | 3,305 | -15 | -0.5% | 20,300 |
| 2023/11/08 | 3,300 | 3,330 | 3,280 | 3,320 | +20 | +0.6% | 26,700 |
| 2023/11/07 | 3,335 | 3,360 | 3,295 | 3,300 | -50 | -1.5% | 32,100 |
| 2023/11/06 | 3,395 | 3,400 | 3,310 | 3,350 | +25 | +0.8% | 49,300 |
| 2023/11/02 | 3,320 | 3,380 | 3,310 | 3,325 | -65 | -1.9% | 28,500 |
| 2023/11/01 | 3,380 | 3,395 | 3,360 | 3,390 | +80 | +2.4% | 45,100 |
| 2023/10/31 | 3,225 | 3,320 | 3,225 | 3,310 | +105 | +3.3% | 41,100 |
| 2023/10/30 | 3,260 | 3,290 | 3,190 | 3,205 | -120 | -3.6% | 42,100 |
| 2023/10/27 | 3,275 | 3,325 | 3,255 | 3,325 | +70 | +2.2% | 29,500 |
| 2023/10/26 | 3,280 | 3,320 | 3,240 | 3,255 | -45 | -1.4% | 37,000 |
| 2023/10/25 | 3,310 | 3,330 | 3,300 | 3,300 | -10 | -0.3% | 17,600 |
| 2023/10/24 | 3,310 | 3,325 | 3,245 | 3,310 | -15 | -0.5% | 21,200 |
| 2023/10/23 | 3,295 | 3,350 | 3,295 | 3,325 | +15 | +0.5% | 27,000 |
| 2023/10/20 | 3,280 | 3,330 | 3,280 | 3,310 | +20 | +0.6% | 19,400 |
| 2023/10/19 | 3,230 | 3,305 | 3,230 | 3,290 | +30 | +0.9% | 23,800 |
| 2023/10/18 | 3,295 | 3,295 | 3,215 | 3,260 | +15 | +0.5% | 24,300 |
| 2023/10/17 | 3,240 | 3,270 | 3,215 | 3,245 | +5 | +0.2% | 25,300 |
| 2023/10/16 | 3,215 | 3,275 | 3,210 | 3,240 | -30 | -0.9% | 27,800 |
| 2023/10/13 | 3,320 | 3,320 | 3,270 | 3,270 | -70 | -2.1% | 16,900 |
| 2023/10/12 | 3,365 | 3,365 | 3,315 | 3,340 | -5 | -0.1% | 12,800 |
| 2023/10/11 | 3,375 | 3,375 | 3,330 | 3,345 | -10 | -0.3% | 24,900 |
| 2023/10/10 | 3,350 | 3,370 | 3,330 | 3,355 | +35 | +1.1% | 26,700 |
| 2023/10/06 | 3,270 | 3,340 | 3,270 | 3,320 | +40 | +1.2% | 21,900 |
| 2023/10/05 | 3,205 | 3,285 | 3,205 | 3,280 | +75 | +2.3% | 32,600 |
| 2023/10/04 | 3,200 | 3,235 | 3,175 | 3,205 | -5 | -0.2% | 25,800 |
| 2023/10/03 | 3,285 | 3,290 | 3,210 | 3,210 | -75 | -2.3% | 31,900 |
| 2023/10/02 | 3,370 | 3,370 | 3,285 | 3,285 | -50 | -1.5% | 33,200 |
| 2023/09/29 | 3,365 | 3,370 | 3,320 | 3,335 | -30 | -0.9% | 26,800 |
| 2023/09/28 | 3,380 | 3,400 | 3,345 | 3,365 | -90 | -2.6% | 29,300 |
| 2023/09/27 | 3,370 | 3,455 | 3,360 | 3,455 | +80 | +2.4% | 46,300 |
| 2023/09/26 | 3,375 | 3,410 | 3,360 | 3,375 | -30 | -0.9% | 23,600 |
| 2023/09/25 | 3,355 | 3,425 | 3,355 | 3,405 | +50 | +1.5% | 32,300 |
| 2023/09/22 | 3,355 | 3,370 | 3,345 | 3,355 | -30 | -0.9% | 24,700 |
| 2023/09/21 | 3,400 | 3,430 | 3,380 | 3,385 | -10 | -0.3% | 21,100 |
| 2023/09/20 | 3,435 | 3,440 | 3,385 | 3,395 | -40 | -1.2% | 31,500 |
| 2023/09/19 | 3,420 | 3,445 | 3,410 | 3,435 | -5 | -0.1% | 25,500 |
| 2023/09/15 | 3,415 | 3,465 | 3,390 | 3,440 | +25 | +0.7% | 66,800 |
| 2023/09/14 | 3,390 | 3,425 | 3,375 | 3,415 | +10 | +0.3% | 22,400 |
| 2023/09/13 | 3,395 | 3,410 | 3,360 | 3,405 | +20 | +0.6% | 34,000 |
| 2023/09/12 | 3,340 | 3,395 | 3,340 | 3,385 | +55 | +1.7% | 27,300 |
| 2023/09/11 | 3,330 | 3,345 | 3,295 | 3,330 | +20 | +0.6% | 35,600 |
| 2023/09/08 | 3,350 | 3,370 | 3,310 | 3,310 | -70 | -2.1% | 47,800 |
401～
450
件表示中 / 3740件
類似銘柄と比較する
現在ご覧いただいている「持田薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 持田薬 | 290,800円 | +5.1% | -7.0% | 2.75% | 19.09倍 | 0.79倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| サンバイオ | 216,600円 | - | - | 0.00% | - | 100.32倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
| ゼリア新薬 | 205,100円 | +3.1% | -6.5% | 2.34% | 9.52倍 | 1.01倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| 杏林製薬 | 150,000円 | -2.4% | -52.3% | 3.80% | 17.95倍 | 0.63倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| ネクセラファーマ | 88,200円 | +20.3% | - | 0.00% | 156.38倍 | 1.16倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
市場注目の銘柄
チャート関連のコラム
